Phase II trial of nab-paclitaxel compared with docetaxel as first-line chemotherapy in patients with metastatic breast cancer: final analysis of overall survival (Q47584504)
Jump to navigation
Jump to search
scientific article published on 23 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of nab-paclitaxel compared with docetaxel as first-line chemotherapy in patients with metastatic breast cancer: final analysis of overall survival |
scientific article published on 23 June 2012 |
Statements
1 reference
Phase II trial of nab-paclitaxel compared with docetaxel as first-line chemotherapy in patients with metastatic breast cancer: final analysis of overall survival (English)
1 reference
William J Gradishar
1 reference
Dimitry Krasnojon
1 reference
Sergey Cheporov
1 reference
Anatoly N Makhson
1 reference
Georgiy M Manikhas
1 reference
Alicia Clawson
1 reference
Paul Bhar
1 reference
John R McGuire
1 reference
Jose Iglesias
1 reference
23 June 2012
1 reference
12
1 reference
5
1 reference
313-321
1 reference